Simultaneously, they found that inhibition of CDK5 activity can regulate the continuous expression of interferon regulatory factor 2 (IRF2) and interferon IRF2BP2 in medulloblastoma (MB) mouse model, decreasing PD-L1 expression and then eliminating immune evasion [72]. The gene discussed is IRF2; the disease is medulloblastoma.